Dexcom G6 and Pro CGM Systems


Dexcom G6 personal system

Dexcom G6 CGM

Dexcom G6 CGM is the first real-time, integrated continuous glucose monitoring (iCGM) system authorized to work with a range of connected insulin pen and hybrid closed-loop system partners.

  • Insulin pump and pen connections
  • Adult and pediatric patients ages 2 years+ with type 1 or type 2 diabetes
  • Comprehensive insights
Dexcom G6 Pro system

Dexcom G6 Pro CGM

The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is a practice-owned, professional diabetes management tool with the accuracy of the Dexcom G6 CGM System for personal use.

  • Blinded or unblinded mode 
for personalized planning
  • Patients with or without diabetes
  • Simplified office workflow

Compare CGM System


Personal or Pro, Dexcom G6 CGM Systems enhances your care.


Accuracy and outcomes

Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.2,3,10-12

Icon for real-time continuous glucose monitoring

Real-time continuous glucose monitoring (RT-CGM)

Real-time glucose readings are sent straight to your patient's smart device* or receiver whenever, wherever.

icon no fingersticks


Neither Dexcom G6 Personal nor Pro require calibrations and both can be used to make treatment decisions without fingersticks.


Real-Time Alerts

When the Dexcom G6 Pro is used in unblinded mode, the Urgent Low Soon Alert can warn patients in advance of potentially dangerous low glucose values (55 mg/dL or below) and is associated with reduced hypoglycemia, without a corresponding increase in hyperglycemia.§,4

icon follow


Your patients can choose to share their glucose data with up to 10|| followers. Should patients also give their followers the ability to receive alert notifications, followers can help patients stay in range.


Dexcom Clarity compatibility

Use of the Dexcom Clarity software and reports can facilitate better conversations about a patient’s Dexcom G6 glucose data during telehealth or in-person visits.

If your glucose alerts and readings from the Dexcom G6 CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.



* Compatible smart devices sold separately:

Mean absolute relative difference (MARD) is a statistical measure of accuracy.

§ This predictive alert can be triggered with impending hypoglycemia (glucose of 55 mg/dL or below is predicted to occur within the next 20 minutes).

|| Separate Dexcom Follow app required. Internet connectivity required for data sharing. Followers should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions. Followers must have compatible smart devices to use the Dexcom Follow app.

2 Beck RW, et al. JAMA. 2017;317(4):371-378.

3 Welsh JB et al. Diabetes Technol Ther. 2019;21(3):128-132.

4 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Contact Reason

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Dexcom G7 samples are the only version currently available online.

Do not include prefix (Mr., Mrs., Dr.)
As listed on Provider’s medical license (no MD, Jr., Sr.)
Please use the Provider's NPI
Is your patient on a connected pump device?


By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.